abstract |
The present invention relates to methods, compounds and compositions for treating or preventing diseases associated with nonsense mutations in mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds and compositions for inhibiting premature translation termination associated with nonsense mutations in mRNA. |